ITI-1284 is under clinical development by Intra-Cellular Therapies and currently in Phase II for Generalized Anxiety Disorder (GAD).

Scientists have identified the brain circuits behind panic attacks, offering insights into new treatments for panic disorder.

J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.

People with generalized anxiety disorder (GAD), however ... Both mental health treatment and medication can help reduce symptoms of GAD.

Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder ... any psychotropic medication 239 64.1 SSRIs ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...

Johnson amp Johnson JampJ the American multinational pharmaceutical biotechnology and medical technologies corporation agreed to acquire men ...

A man accused of killing his wife and stepson in Henderson was found competent by a judge Wednesday, which means his case ...

(Note, too, that IAD often overlaps with other mental health conditions such as generalized anxiety disorder or depression ... and sometimes medication, patients can learn to manage their ...

A. Antidepressants are approved for use by the Food and Drug Administration in major depressive disorder, some of them in ...